These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7582396)

  • 21. In vivo performance of controlled release pellets of diltiazem HCl.
    Nisarur-ur-Rahman ; K H Y; Jia Woei W
    Pak J Pharm Sci; 2005 Apr; 18(2):44-8. PubMed ID: 16431398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The pharmacokinetic behavior of AWD 26-06 in humans following single and multiple administration].
    Terhaag B; Richter K; Feller K
    Pharmazie; 1992 Jan; 47(1):43-5. PubMed ID: 1608984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of male-female differences in disposition and esterase hydrolysis of ramipril to ramiprilat in healthy volunteers after a single oral dose.
    Vree TB; Dammers E; Ulc I; Horkovics-Kovats S; Ryska M; Merkx ; Ijsbrand
    ScientificWorldJournal; 2003 Dec; 3():1332-43. PubMed ID: 14755115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HPLC determination of diltiazem in human plasma and its application to pharmacokinetics in humans.
    Li K; Zhang X; Zhao F
    Biomed Chromatogr; 2003 Dec; 17(8):522-5. PubMed ID: 14648609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic and pharmacodynamic interactions between simvastatin and diltiazem in patients with hypercholesterolemia and hypertension.
    Watanabe H; Kosuge K; Nishio S; Yamada H; Uchida S; Satoh H; Hayashi H; Ishizaki T; Ohashi K
    Life Sci; 2004 Dec; 76(3):281-92. PubMed ID: 15531380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates.
    Lemma GL; Wang Z; Hamman MA; Zaheer NA; Gorski JC; Hall SD
    Clin Pharmacol Ther; 2006 Mar; 79(3):218-30. PubMed ID: 16513446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bioavailability of 3 formulations of diltiazem].
    das Neves HJ; Vital JS; Vasconcelos AM; da Silva MD; Alves P; Santana A; Rocha MP
    Rev Port Cardiol; 1989; 8(7-8):521-4. PubMed ID: 2631854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of tegaserod by LC-ESI-MS/MS and its application to a pharmacokinetic study in healthy Chinese volunteers.
    Zou JJ; Bian XJ; Ding L; Zhu YB; Fan HW; Xiao DW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(1):151-7. PubMed ID: 18069077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic interaction between fluoxetine and metoclopramide in healthy volunteers.
    Vlase L; Leucuta A; Farcau D; Nanulescu M
    Biopharm Drug Dispos; 2006 Sep; 27(6):285-9. PubMed ID: 16770757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioavailability of phenytoin sodium capsules available in Thailand. Part II: In vivo study.
    Suthisisang C; Payakachat N; Chulavatnatol S; Towanabut S
    J Med Assoc Thai; 1998 Jan; 81(1):64-70. PubMed ID: 9470324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and urinary excretion of eprosartan in Chinese healthy volunteers of different gender.
    Xu HR; Chen WL; Li XN; Liu GY; Chu NN; Yu C
    Pharmazie; 2007 Oct; 62(10):782-4. PubMed ID: 18236785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and bioequivalence testing of generic ondansetron preparations in healthy Thai male volunteers.
    Rojanasthien N; Manorot M; Kumsorn B
    Int J Clin Pharmacol Ther; 1999 Nov; 37(11):548-54. PubMed ID: 10584976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacokinetics and relative bioavailability of KC-404 sustained release tablets in healthy volunteers].
    Li T; Pang Y; Wang Z; Jia Y; Cheng Q; Sun J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):541-3. PubMed ID: 12910715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative bioavailability of different butamirate citrate preparations after single dose oral administration to 18 healthy volunteers.
    Bohner H; Janiak PS; Nitsche V; Eichinger A; Schütz H
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):117-22. PubMed ID: 9089001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coadministration of grapefruit juice increases systemic exposure of diltiazem in healthy volunteers.
    Christensen H; Asberg A; Holmboe AB; Berg KJ
    Eur J Clin Pharmacol; 2002 Nov; 58(8):515-20. PubMed ID: 12451428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of mexiletine and its metabolites, hydroxymethylmexiletine and p-hydroxymexiletine, after single oral administration in healthy subjects.
    Paczkowski D; Sadowski Z; Filipek M; Koliński P
    Pol J Pharmacol Pharm; 1990; 42(4):365-75. PubMed ID: 2097598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of epigallocatechin gallate on the bioavailability and pharmacokinetics of diltiazem in rats.
    Li C; Choi JS
    Pharmazie; 2008 Nov; 63(11):815-8. PubMed ID: 19069242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study comparing biopharmaceutic characteristics of four once daily controlled release diltiazem preparations.
    Hendriks MG; Dogterom P; Ebels JT; Oosterhuis B; Geertsema LR; Hulot T; Bianchetti G; Jonkman JH
    Fundam Clin Pharmacol; 1998; 12(5):559-65. PubMed ID: 9794155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative bioavailability of diltiazem in prolonged-release oral preparations.
    Quiroga PA; Yuln GV; Palummo M; Cingolani A; Dall LL; Volonté MG
    Drug Dev Ind Pharm; 2001 Nov; 27(10):1099-106. PubMed ID: 11794812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.